Key result
Steroid therapy and percutaneous cardiopulmonary support successfully improved left ventricular function in a patient with acute fulminant eosinophilic myocarditis and ulcerative colitis, with LVEF recovering to 40.5%.
Case Report (n=1)
No
Steroid therapy combined with percutaneous cardiopulmonary support can improve left ventricular ejection fraction in patients with acute fulminant eosinophilic myocarditis associated with ulcerative colitis.
Single-case success suggests steroids plus support may aid fulminant eosinophilic myocarditis; leaves open generalizability in ulcerative colitis.
A 47-year-old man with ulcerative colitis was transferred to our hospital due to progressive dyspnea. Electrocardiography on admission showed ST elevation in leads II, III, aVF, and V5-V6. Coronary angiography revealed no remarkable coronary stenosis, and left ventriculography showed a depressed left ventricular ejection fraction (EF) of 23%. Although the patient received percutaneous cardiopulmonary support, his EF progressively decreased (7-15%), and both ventricular tachycardia (VT) and high-degree atrial-ventricular block occurred. An endomyocardial biopsy showed eosinophilic infiltration in the myocardium. Steroid therapy improved the patient's EF. However, his severe inferior wall hypokinesis and non-sustained VT remained after the abovementioned treatment.
No takes yet. Share an insight, caveat, or question.
Tagawa et al. (2018) conducted a case report in Acute fulminant eosinophilic myocarditis and ulcerative colitis (n=1). Steroid therapy and percutaneous cardiopulmonary support was evaluated on Left ventricular ejection fraction (LVEF) and clinical recovery. Steroid therapy and percutaneous cardiopulmonary support successfully improved left ventricular function in a patient with acute fulminant eosinophilic myocarditis and ulcerative colitis, with LVEF recovering to 40.5%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: